Dartmouth College Green by Peter Rintels
  • LinkedIn
  • Twitter

Upcoming Event

September 22-24, 2021
Woodstock VT

Dartmouth College Green by Peter Rintels

 

Program From Our
April Event

PROGRAM

3D EFS MDIC
What Makes Early Feasibility Study (EFS) Different?

 
Wednesday April 21
Webinar Begins @ 12PM ET

12:00

Welcome
Pamela Goldberg MBA

President and CEO, MDIC

12:05

Welcome

Jeff Shuren, MD JD

Director, Center for Devices and Radiological Health

FDA

12:10

Framing Comments

Aaron V. Kaplan, MD

Dartmouth Device Development Symposium

Dartmouth-Hitchcock Medical Center

12:20

Interview - What Makes EFS Different?

Clinical Site Perspective

Jaimie Walkowiak, JD

InstilBio

Baylor Scott & White Research Institute

12:35

 What Makes EFS Different - Key Issues/Stumbling Blocks

Indemnification, Reimbursement, Patient Recruitment

 

Moderator:  Chip Hance / Regatta Medical

Presenter:  Examining the Metrics

                  Jon Hunt / MDIC

Panel:

Steven A. Farmer, MD, PhD / Center for Medicare Services

Lynne Goodreau / Northwestern Memorial

Jill Treckell / Edwards Lifesciences

Tamim Nazif, MD / Columbia University

Michael Zapien / Ancora Heart

1:15

Interview - What Makes EFS Different?

A Large Company & Investigator Perspective

Ian Meredith, MD, PhD

Global Chief Medical Officer

Boston Scientific

1:30

EFS Case Study  - Large Company

Interview with

Jeffrey J. Popma, MD
Chief Medical Officer (Coronary & Structural Heart)

Medtronic

1:45

 Expanding EFS Beyond Structural Heart - Learnings for other Disciplines

Moderator:  

Andrew Farb, MD
Centers for Devices and Radiological Health, FDA

Panel

Lauren Baker, PhD / Insight Medical Consulting

Katherine Kumar, PhD / 4C Medical Technologies

Paul Sorajja, MD / Minneapolis Heart

Vivek Reddy, MD / Mt. Sinai Medical Center

2:25

Interview - What Makes EFS Different?

A CDRH/FDA Perspective

Andrew Farb, MD

Chief Medical Officer/Cardiovascular Devices

Centers for Devices and Radiological Health, FDA

2:40

EFS/EU MDD to MDR Transition Implications

Moderator:  Rick Geoffrion / Cyrano Therapeutics

Panel

Olivier Delporte / MiraCor

Hansen Gifford / Lightstone Ventures

Daniel O'Mahoney / Seroba Lifesciences

Nitin Mehta / TUV-Sud

Neil Moat, MD / Abbot Vascular

3:10

Closing Remarks

David Holmes, Jr., MD

Scripps Professor in Cardiovascular Medicine
Mayo Clinic

3:30

ADJOURN

 ABOUT

For almost 20 years the 3D Dartmouth Device Symposium has been bringing together a distinguished group of thought leaders representing the clinical, business, governmental, financial and legal segments of the medical device community.

 

The Symposium provides an important forum to exchange ideas and discuss problems common to us all as we strive to bring new technologies to improve patient care.

 

PANEL
MEMBERS

Alphabetical - Last Name

 
59 DAYS TO THE EVENT
Sep 22, 2:00 PM
Woodstock Inn
 

TEAM

 

HISTORY

History 2003-2009
History 2003-2009

History 2003-2009

History 2010-2016
History 2010-2016

History 2010-2016

History 2017-2021
History 2017-2021

History 2017-2021